Skip to search formSkip to main contentSkip to account menu

NC 6004

Known as: NC-6004, NC6004 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
P3-10-04: A open-label, randomized, parallel, phase III trial to evaluate the efficacy and safety of Genexol ® -PM compared to… 
2016
2016
e14081Background: NC-6004 is polymeric micelle containing cisplatin as active moiety. A phase I study of monotherapy in patients… 
Review
2016
Review
2016
There are two main concepts in drug delivery systems (DDS): passive targeting and active targeting. The passive targeting system… 
2015
2015
In 2000, President Clinton announced the U.S. Government’s National Nanotechnology Initiative to invest in nanotechnology… 
2014
2014
We report an elemental analysis of murine solid tumors treated with cisplatin-incorporated polymeric micelles (NC-6004) to… 
Review
2014
Review
2014
  • G. Kwon
  • 2014
  • Corpus ID: 40198870
This year’s recipient of the Journal of Drug Targeting Life-Time Achievement Award is Professor Kazunori Kataoka. He is a… 
2008
2008
208 NC-6004 is a novel micellar formulation of cisplatin. The micelles (M Wt 660,000) are composed of cisplatin residues…